Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S; IARC HPV Prevalence Surveys Study Group.

Lancet. 2005 Sep 17-23;366(9490):991-8.

PMID:
16168781
2.

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX.

Lancet Infect Dis. 2007 Jul;7(7):453-9. Review.

PMID:
17597569
3.

High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy.

Tornesello ML, Cassese R, De Rosa N, Buonaguro L, Masucci A, Vallefuoco G, Palmieri S, Schiavone V, Piccoli R, Buonaguro FM.

APMIS. 2011 Oct;119(10):701-9. doi: 10.1111/j.1600-0463.2011.02784.x. Epub 2011 Jun 23.

PMID:
21917007
4.

Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.

Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L.

J Med Virol. 2009 Mar;81(3):529-35. doi: 10.1002/jmv.21347.

PMID:
19152401
5.

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N.

Int J Cancer. 2006 Dec 1;119(11):2677-84.

6.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J; CLEOPATRE Spain Study Group.

J Med Virol. 2012 Jun;84(6):947-56. doi: 10.1002/jmv.23282.

PMID:
22499018
7.

Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.

Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Syrjänen SM; NIS Study Group.

J Med Virol. 2007 Jun;79(6):771-81.

PMID:
17457909
8.

[Prevalence of human papilloma virus and analysis of its risk factors in Daqing city, Heilongjiang province in 2010].

Yang L, Li N, Guo LW, Li Q, Cui H, Dai M.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Feb;47(2):118-23. Chinese.

PMID:
23719101
9.

Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain.

de Oña M, Alvarez-Argüelles ME, Torrents M, Villa L, Rodriguez-Feijoo A, Palacio A, Boga JA, Tamargo A, Melón S.

J Med Virol. 2010 Apr;82(4):597-604. doi: 10.1002/jmv.21697.

PMID:
20166173
10.

Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer.

Baay MF, Tjalma WA, Weyler J, Goovaerts G, Buytaert P, Van Marck EA, Lardon F, Vermorken JB.

Eur J Gynaecol Oncol. 2001;22(3):204-8.

PMID:
11501772
11.

Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.

Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, Macis R, Pini MT, Chini F, Carozzi FM; HPV Prevalence Italian Working Group.

BMC Infect Dis. 2010 Jul 20;10:214. doi: 10.1186/1471-2334-10-214.

12.

Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Munoz M, Camargo M, Soto-De Leon SC, Sanchez R, Parra D, Pineda AC, Sussmann O, Perez-Prados A, Patarroyo ME, Patarroyo MA.

PLoS One. 2013;8(2):e56509. doi: 10.1371/journal.pone.0056509. Epub 2013 Feb 13.

13.

Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Ye J, Cheng X, Chen X, Ye F, Lü W, Xie X.

Virol J. 2010 Mar 23;7:66. doi: 10.1186/1743-422X-7-66.

14.

Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.

Učakar V, Poljak M, Oštrbenk A, Klavs I.

J Med Virol. 2014 Oct;86(10):1772-9. doi: 10.1002/jmv.23997. Epub 2014 Jun 30.

PMID:
24978445
15.

Prevalence of human papillomavirus genotypes in northern Taiwanese women.

Tsao KC, Huang CG, Kuo YB, Chang TC, Sun CF, Chang CA, Yang SL, Chan EC.

J Med Virol. 2010 Oct;82(10):1739-45. doi: 10.1002/jmv.21870.

PMID:
20827772
16.

Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.

Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.

Cytopathology. 2009 Aug;20(4):249-55. doi: 10.1111/j.1365-2303.2008.00611.x. Epub 2008 Oct 24.

PMID:
19018810
17.

Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.

Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ.

Int J Cancer. 2000 Jul 15;87(2):221-7.

18.

Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.

PMID:
23199955
19.

Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women.

Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ, Ryd W, Rylander E, Strand A, Wadell G, Dillner J, Johansson B.

J Med Virol. 2002 Apr;66(4):535-41. Erratum in: J Med Virol 2002 Jul;67(3):467.

PMID:
11857534
20.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720

Supplemental Content

Support Center